Log in

Evelo Biosciences News Headlines (NASDAQ:EVLO)

$5.02
+0.63 (+14.35 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$4.26
Now: $5.02
$5.18
50-Day Range
$3.62
MA: $4.81
$7.06
52-Week Range
$3.58
Now: $5.02
$10.09
Volume305,231 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Evelo Biosciences (NASDAQ EVLO) News Headlines

Source:
DateHeadline
Evelo Biosciences, Inc. (EVLO) CEO Balkrishan Gill on Q4 2019 Results - Earnings Call TranscriptEvelo Biosciences, Inc. (EVLO) CEO Balkrishan Gill on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 14 at 2:51 PM
Evelo Biosciences (NASDAQ:EVLO) Releases Quarterly  Earnings Results, Misses Estimates By $0.05 EPSEvelo Biosciences (NASDAQ:EVLO) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
www.americanbankingnews.com - February 14 at 1:23 PM
Evelo Biosciences (NASDAQ:EVLO) Rating Reiterated by CowenEvelo Biosciences (NASDAQ:EVLO) Rating Reiterated by Cowen
www.americanbankingnews.com - February 14 at 7:37 AM
Evelo Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Business HighlightsEvelo Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
finance.yahoo.com - February 13 at 8:20 AM
Evelo Biosciences (EVLO) Scheduled to Post Earnings on ThursdayEvelo Biosciences (EVLO) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - February 7 at 10:36 AM
Evelo Biosciences to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020Evelo Biosciences to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020
finance.yahoo.com - February 6 at 11:25 AM
AMRS, INSM, NNVC and EYES among midday moversAMRS, INSM, NNVC and EYES among midday movers
seekingalpha.com - February 3 at 1:24 PM
Evelo Biosciences Inc (NASDAQ:EVLO) Expected to Announce Earnings of -$0.65 Per ShareEvelo Biosciences Inc (NASDAQ:EVLO) Expected to Announce Earnings of -$0.65 Per Share
www.americanbankingnews.com - January 23 at 12:46 AM
Evelo Bio up 7% on improved timeline for lead candidateEvelo Bio up 7% on improved timeline for lead candidate
seekingalpha.com - January 10 at 4:24 PM
Evelo Provides Update on Recent Positive EDP1815 Regulatory Interactions on Phase 2 Trial Design Resulting in Shorter Development Timeline to RegistrationEvelo Provides Update on Recent Positive EDP1815 Regulatory Interactions on Phase 2 Trial Design Resulting in Shorter Development Timeline to Registration
finance.yahoo.com - January 10 at 4:24 PM
Hedge Funds Have Never Been This Bullish On Evelo Biosciences, Inc. (EVLO)Hedge Funds Have Never Been This Bullish On Evelo Biosciences, Inc. (EVLO)
finance.yahoo.com - December 20 at 10:29 PM
Evelo Biosciences Appoints Juan Andres to Board of DirectorsEvelo Biosciences Appoints Juan Andres to Board of Directors
finance.yahoo.com - December 5 at 9:03 AM
Evelo Biosciences to Present at the Stifel 2019 Healthcare ConferenceEvelo Biosciences to Present at the Stifel 2019 Healthcare Conference
finance.yahoo.com - November 13 at 9:05 AM
Evelo Biosciences to Present Preclinical Data from its EDP1503 Oncology Program at the Society for Immunotherapy of Cancer’s (SITC) Annual MeetingEvelo Biosciences to Present Preclinical Data from its EDP1503 Oncology Program at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
finance.yahoo.com - November 8 at 9:50 AM
Evelo Biosciences EPS misses by $0.08Evelo Biosciences EPS misses by $0.08
seekingalpha.com - November 5 at 7:58 AM
Evelo Biosciences Announces Further Positive Interim Phase 1b Clinical Data in Psoriasis and Reports Third Quarter 2019 Financial ResultsEvelo Biosciences Announces Further Positive Interim Phase 1b Clinical Data in Psoriasis and Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 5 at 7:58 AM
Evelo Biosciences Reports Further Positive EDP1815 Interim Clinical Data in Patients with Psoriasis at High Dose in Phase 1b TrialEvelo Biosciences Reports Further Positive EDP1815 Interim Clinical Data in Patients with Psoriasis at High Dose in Phase 1b Trial
finance.yahoo.com - November 5 at 7:58 AM
Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, November 5th Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, November 5th 
finance.yahoo.com - October 29 at 9:46 AM
Evelo Biosciences to Present at the 2019 Cantor Global Healthcare ConferenceEvelo Biosciences to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 26 at 5:03 PM
Evelo Biosciences to Host Key Opinion Leader Symposium on Unmet Need in Mild to Moderate Psoriasis and Potential for EDP1815Evelo Biosciences to Host Key Opinion Leader Symposium on Unmet Need in Mild to Moderate Psoriasis and Potential for EDP1815
finance.yahoo.com - September 20 at 12:48 PM
EVLO Evelo Biosciences, Inc. Common StockEVLO Evelo Biosciences, Inc. Common Stock
www.nasdaq.com - September 13 at 9:37 AM
Evelo Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare ConferenceEvelo Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
finance.yahoo.com - September 3 at 12:40 PM
Evelo Biosciences (EVLO) CEO Simba Gill on Q2 2019 Results - Earnings Call TranscriptEvelo Biosciences (EVLO) CEO Simba Gill on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 12:11 PM
Evelo Biosciences, Inc. (EVLO) Q2 2019 Earnings Call TranscriptEvelo Biosciences, Inc. (EVLO) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 7 at 1:19 PM
Early-stage data on Evelos EDP1815 fails to excite investors, shares down 10%Early-stage data on Evelo's EDP1815 fails to excite investors, shares down 10%
seekingalpha.com - August 6 at 12:12 PM
Evelo Biosciences Announces Positive Interim Phase 1b Clinical Data and Provides Second Quarter 2019 Financial ResultsEvelo Biosciences Announces Positive Interim Phase 1b Clinical Data and Provides Second Quarter 2019 Financial Results
finance.yahoo.com - August 6 at 12:12 PM
Evelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b TrialEvelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b Trial
finance.yahoo.com - August 6 at 12:12 PM
Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, August 6thEvelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, August 6th
finance.yahoo.com - July 30 at 11:47 AM
Evelo Biosciences Secures $45 Million Debt Financing from K2 HealthVenturesEvelo Biosciences Secures $45 Million Debt Financing from K2 HealthVentures
finance.yahoo.com - July 25 at 1:59 PM
Introducing Evelo Biosciences (NASDAQ:EVLO), The Stock That Slid 53% In The Last YearIntroducing Evelo Biosciences (NASDAQ:EVLO), The Stock That Slid 53% In The Last Year
finance.yahoo.com - May 27 at 11:08 AM
Evelo Biosciences Inc.Evelo Biosciences Inc.
www.barrons.com - May 22 at 4:03 PM
Evelo Biosciences, Inc. (EVLO) CEO Balkrishan Gill on Q1 2019 Results - Earnings Call TranscriptEvelo Biosciences, Inc. (EVLO) CEO Balkrishan Gill on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 3:37 PM
Evelo Biosciences, Inc. (EVLO) Q1 2019 Earnings Call TranscriptEvelo Biosciences, Inc. (EVLO) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 5 at 10:37 AM
Evelo Biosciences Reports First Quarter 2019 Financial Results and Recent Business HighlightsEvelo Biosciences Reports First Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - May 2 at 11:55 AM
Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Thursday, May 2, 2019Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Thursday, May 2, 2019
finance.yahoo.com - April 25 at 11:40 AM
Evelo Biosciences to Present at 18th Annual Needham Healthcare ConferenceEvelo Biosciences to Present at 18th Annual Needham Healthcare Conference
finance.yahoo.com - April 3 at 8:45 AM
Evelo Biosciences IncEvelo Biosciences Inc
www.bloomberg.com - March 19 at 11:22 AM
Evelo Biosciences to Present at 39th Annual Cowen & Co. Health Care ConferenceEvelo Biosciences to Present at 39th Annual Cowen & Co. Health Care Conference
finance.yahoo.com - March 4 at 8:49 AM
Evelo Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business HighlightsEvelo Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
finance.yahoo.com - February 14 at 11:42 AM
Evelo Biosciences to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 14, 2019Evelo Biosciences to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 14, 2019
finance.yahoo.com - February 7 at 11:42 AM
Mid-stage melanoma study of Evelos EDP1503 + Keytruda underwayMid-stage melanoma study of Evelo's EDP1503 + Keytruda underway
seekingalpha.com - January 28 at 11:42 AM
Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic MelanomaEvelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma
finance.yahoo.com - January 28 at 11:42 AM
Evelo Biosciences doses first patient in Phase 1/2 trial of EDP1503 in combination with KEYTRUDAEvelo Biosciences doses first patient in Phase 1/2 trial of EDP1503 in combination with KEYTRUDA
seekingalpha.com - January 4 at 9:28 AM
Evelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology IndicationsEvelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology Indications
finance.yahoo.com - January 4 at 9:28 AM
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel